Cover Image

Ebronucimab in Chinese patients with hypercholesterolemia---A randomized double-blind placebo-controlled phase 3 trial to evaluate the efficacy and safety of ebronucimab

Randomized clinical trials (RCTs) of PCSK9 monoclonal antibody(mAb) specifically for Chinese patients have been limited. This multi-center RCT is to clarify the efficacy and safety of a novel mAb, Ebronucimab, in Chinese patients. Patients diagnosed with primary hypercholesterolemia, including Heter...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yanyan Zhang (Author), Zhaohui Pei (Author), Beijian Chen (Author), Yanling Qu (Author), Xiaolin Dong (Author), Binge Yu (Author), Guoqin Wang (Author), Fang Xu (Author), Dongmei Lu (Author), Zhimei He (Author), Benchao Chen (Author), Lei Ma (Author), Max Wang (Author), Baiyong Li (Author), Michelle Xia (Author), Bo Zheng (Author), Yong Huo (Author)
Format:	Book
Published:	Elsevier, 2024-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Safety, Pharmacokinetics and Preliminary Efficacy of IL4-Rα Monoclonal Antibody AK120 in Both Healthy and Atopic Dermatitis Subjects: A Phase I, Randomized, Two-Part, Double-Blind, Placebo-Controlled, Dose-Escalation, First-In-Human Clinical Study
by: Christopher John Wynne, et al.
Published: (2023)

Tafolecimab in Chinese patients with non-familial hypercholesterolemia (CREDIT-1): a 48-week randomized, double-blind, placebo-controlled phase 3 trialResearch in context
by: Yong Huo, et al.
Published: (2023)

Population pharmacokinetic/pharmacodynamic analysis of AK111, an IL-17A monoclonal antibody, in subjects with moderate-to-severe plaque psoriasis
by: Qian Li, et al.
Published: (2022)

Efficacy and Tolerability of a Nutraceutical Combination (Red Yeast Rice, Policosanols, and Berberine) in Patients with Low-Moderate Risk Hypercholesterolemia: A Double-Blind, Placebo-Controlled Study
by: Stefano Gonnelli, MD, et al.
Published: (2015)

Comparison of therapeutic and short term side effects of anethum with nicotinic acid, cholestyramine, the combination of the two, and placebo for isolated hypercholesterolemia a double blind, randomized clinical trial
by: A Fotouhi, et al.
Published: (2002)

Treatment of migraines with Tianshu capsule: a multi-center, double-blind, randomized, placebo-controlled clinical trial
by: Shengyuan Yu, et al.
Published: (2019)

Hypercholesterolemia
Published: (2015)

Targeting CD47/SIRPα as a therapeutic strategy, where we are and where we are headed
by: Tailong Qu, et al.
Published: (2022)

Clinical pharmacokinetics and pharmacodynamics of ongericimab: A potential long‐acting PCSK9 monoclonal antibody in healthy subjects and patients with hypercholesterolemia: Randomized, double‐blind, placebo‐controlled phase Ia and Ib/II studies
by: Juanjuan Jiang, et al.
Published: (2024)

A double-blind placebo needle for acupuncture research
by: Takakura Nobuari, et al.
Published: (2007)

The burden of severe hypercholesterolemia and familial hypercholesterolemia in a population-based setting in the US
by: Seyedmohammad Saadatagah, et al.
Published: (2022)

Single blind placebo-controlled study on hypolipidemic potential of drugs
by: Akbar Khan Niazi, et al.
Published: (2018)

Effect of Different Doses of Butorphanol on Postoperative Shivering in Elderly Patients: A Randomized, Double-Blind, Placebo-Controlled Trial
by: Wang Y, et al.
Published: (2023)

Efficacy of Mudan Granule (Combined With Methylcobalamin) on Type 2 Diabetic Peripheral Neuropathy: Study Protocol for a Double-Blind, Randomized, Placebo-Controlled, Parallel-Arm, Multi-Center Trial
by: Yuehong Zhang, et al.
Published: (2021)

Ludangshen oral liquid for treatment of convalescent COVID-19 patients: a randomized, double-blind, placebo-controlled multicenter trial
by: Xuedong An, et al.
Published: (2022)

Efficacy and safety of a Chinese herbal formula Maxing Ganshi Decoction in children with community-acquired pneumonia: A randomized, double-blind, placebo-controlled, multicenter trial
by: Yujiao Zheng, et al.
Published: (2022)

Tendinous xanthoma with familial hypercholesterolemia
by: Alok Kumar Roy, et al.
Published: (2014)

Xanthoma Tendinosum And Familial Hypercholesterolemia
by: Mahajan Vikram K, et al.
Published: (2003)

PROPORTION OF PSORIASIS IN FAMILIAL HYPERCHOLESTEROLEMIA
by: Samip Sheth, et al.
Published: (2021)

Familial hypercholesterolemia: A review
by: Mithun J Varghese
Published: (2014)

The effects of intramuscular administration of scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled trial
by: Jingjing Zhou, et al.
Published: (2020)

Efficacy of Xinbao pill on chronic heart failure: Study protocol of a multicenter, randomized, double-blind, placebo-controlled trial
by: Yuanping Wang, et al.
Published: (2022)

The effects of qishen granules for patients with chronic heart failure: A multicenter randomized double-blind placebo-controlled trial
by: Kangjia Du, et al.
Published: (2022)

Allergic Rhinitis Improvement in Asthmatic Children After Using Acaricidal Bait: A Randomized, Double-Blind, Cross-Placebo Study
by: Ming Chen, et al.
Published: (2021)

Pingchan Granule for Motor Symptoms and Non-Motor Symptoms of Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Study
by: Si-Chun Gu, et al.
Published: (2022)

Cariprazine in therapy of visual hallucinations. Randomized, double-blind placebo-controlled study
by: NA Aliyev, et al.
Published: (2021)

Penehyclidine for Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Gynecological Laparoscopic Surgery Under Combined Intravenous and Inhalation Anesthesia: A Randomized, Double-Blind, Placebo-Controlled Trial
by: Zhao K, et al.
Published: (2024)

Familial hypercholesterolemia with multiple cutaneous xanthomas
by: Reddy BSN, et al.
Published: (2006)

Familial hypercholesterolemia in Southeast and East Asia
by: Candace L. Jackson, et al.
Published: (2021)

Hypercholesterolemia and microvascular dysfunction: interventional strategies
by: James Milinda E, et al.
Published: (2010)

Novel Experimental Agents for the Treatment of Hypercholesterolemia
by: Pećin I, et al.
Published: (2021)

ECONOMIC BURDEN OF HYPERCHOLESTEROLEMIA IN THE RUSSIAN FEDERATION
by: A. V. Kontsevaya, et al.
Published: (2018)

Diagnostic Characteristics of Familial Hypercholesterolemia in Children
by: Dinara I. Sadykova, et al.
Published: (2020)

Xanthoma tuberosum in homozygous familial hypercholesterolemia
by: Nagaraja Moorthy, et al.
Published: (2014)

Letter to the Editor Regarding: Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study
by: Ruiyao Hu, et al.
Published: (2024)

Randomized, double-blind, placebo-controlled trial of aripiprazole oral solution in children and adolescents with Tourette's disorder
by: Fan He, et al.
Published: (2024)

It is Time to Screen for Homozygous Familial Hypercholesterolemia in the United States
by: Samuel S. Gidding, et al.
Published: (2024)

Engineering lentivirus envelope VSV-G for liver targeted delivery of IDOL-shRNA to ameliorate hypercholesterolemia and atherosclerosis
by: Wei Wang, et al.
Published: (2024)

Synthesized economic evidence on the cost-effectiveness of screening familial hypercholesterolemia
by: Mengying Wang, et al.
Published: (2024)

Traditional Chinese Medicine Combined With Chemotherapy and Cetuximab or Bevacizumab for Metastatic Colorectal Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
by: Ningning Liu, et al.
Published: (2020)